Terbinafine
Is It Right for You?
A complete guide to Terbinafine — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Terbinafine?
Terbinafine is an allylamine antifungal medication used to treat a range of fungal skin, nail, and scalp infections. It is one of the most effective and widely used antifungals available, particularly for dermatophyte infections — the class of fungi most commonly responsible for conditions such as tinea pedis (athlete's foot), tinea corporis (ringworm), tinea cruris (jock itch), tinea capitis (scalp ringworm), and onychomycosis (fungal nail infection).
Terbinafine is available in multiple formulations: 250 mg oral tablets (prescription-only) for systemic treatment of nail and scalp infections, and topical preparations including 1% cream, gel, and spray (available over the counter) for superficial skin infections. The oral form achieves high drug concentrations in the skin, hair follicles, and nails — the very tissues where dermatophyte infections reside — making it the most effective treatment for nail fungus and scalp tinea.
One of terbinafine's key advantages is its fungicidal activity — it kills fungi outright rather than simply inhibiting their growth, contributing to higher cure rates and lower rates of relapse compared to older fungistatic antifungals such as griseofulvin. Oral terbinafine for fungal nail infections has a cure rate of approximately 70–80% for toenails and higher for fingernails.
Oral terbinafine is a prescription-only medication in the UK. Topical formulations are available over the counter for skin infections.
What Conditions Is Terbinafine Used For?
Oral terbinafine (250 mg tablets) is indicated for:
dermatophyte infection of the fingernails or toenails; oral terbinafine is the gold-standard first-line treatment.
dermatophyte infection of the scalp and hair follicles; topical treatment alone is insufficient and oral therapy is required.
ringworm of the body or groin where topical treatment has failed or infection is too extensive.
Terbinafine has limited activity against Candida species and is not effective for oral thrush, vaginal candidiasis, or other Candida-related infections. Seek clinical assessment if unsure of the type of fungal infection.
How Does Terbinafine Work?
Terbinafine works by inhibiting squalene epoxidase, a fungal enzyme that is an essential step in the biosynthesis of ergosterol — the principal sterol component of fungal cell membranes. Ergosterol performs a structural role equivalent to cholesterol in human cell membranes, maintaining membrane integrity and function.
By blocking squalene epoxidase, terbinafine causes two simultaneous damaging effects on fungal cells:
- Ergosterol depletion — the fungal cell membrane becomes structurally compromised, increasing permeability and impairing membrane-dependent cellular functions.
- Squalene accumulation — squalene, the substrate for the blocked enzyme, builds up to toxic intracellular levels, directly damaging the fungal cell.
The combination of these effects results in fungicidal activity — the fungal cell is killed rather than merely inhibited. Because squalene epoxidase is a fungal-specific enzyme not present in human cells, terbinafine has a highly selective mechanism of action with a good safety profile for the host.
Terbinafine is highly lipophilic (fat-soluble) and accumulates at very high concentrations in keratin-rich tissues — skin, nails, and hair — which are precisely the tissues infected by dermatophytes. These high tissue concentrations persist long after treatment ends, contributing to sustained antifungal activity.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Oral terbinafine can be taken with or without food. There is no clinically significant food interaction. Taking it at the same time each day helps maintain consistent drug levels.
For nail infections, physical improvement lags significantly behind treatment. Because terbinafine works on the growing nail, you will not see a clear nail until the infected nail has grown out — which takes months. For toenails, full visible improvement may not be apparent until 6–12 months after completing the course, even when treatment has been successful.
Complete the full course, even if the nail or skin appears improved before the course ends. Premature cessation significantly increases relapse rates.
Topical preparations should be applied to clean, dry skin and a small margin around the visible infection. Do not cover with occlusive dressings unless instructed.
Side Effects of Terbinafine
Oral terbinafine is generally well tolerated, with most side effects being mild and transient.
- Gastrointestinal symptoms — nausea, diarrhoea, abdominal discomfort
- Headache
- Rash or urticaria
- Taste disturbance
- Joint and muscle pain
- Severe hepatotoxicity — discontinue immediately if symptoms of liver damage occur.
Serious liver injury has been reported with oral terbinafine. Monitor for symptoms of liver problems and assess liver function before treatment in high-risk patients.
Drug Interactions
Terbinafine may interact with warfarin, antidepressants, and other medications. Always inform your clinician about all medications you are taking.
Terbinafine may alter warfarin metabolism, increasing anticoagulant effect and bleeding risk. INR should be monitored during and after terbinafine courses.
A strong CYP enzyme inducer that significantly increases terbinafine metabolism and reduces its plasma levels, potentially reducing efficacy. Dose adjustment may be required.
Terbinafine inhibits CYP2D6, increasing plasma levels of drugs metabolised by this enzyme, including many antidepressants. Increased side effects or toxicity of the antidepressant may result. Dose adjustment of the antidepressant may be necessary.
Terbinafine may increase blood levels of these drugs. Monitor for increased pharmacological effects.
Important Warnings
Serious hepatotoxicity has been reported with oral terbinafine, including fatal cases of liver failure. Patients should be counselled to report symptoms of liver problems immediately — particularly jaundice, dark urine, pale stools, or unusual fatigue. Liver function testing should be considered before treatment and during prolonged courses.
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis have been reported. Terbinafine should be discontinued immediately if a progressive skin rash develops, and medical care sought urgently.
Terbinafine can cause taste and smell disturbances that usually resolve on stopping the drug. In rare cases, taste loss may be prolonged. Patients who develop significant taste disturbance should discuss this with their clinician, as it may warrant discontinuation.
Terbinafine is metabolised by the liver and excreted renally. It should not be used in patients with significant hepatic or renal impairment. Liver function should be assessed before prescribing in high-risk patients.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Terbinafine FAQs
Yes. A clinician can assess your symptoms and nail or skin presentation via a telehealth consultation and prescribe terbinafine if appropriate. Clear photographs of affected nails or skin can support an accurate assessment.
The success of treatment is not apparent until the infected nail has grown out and been replaced by clear nail. This takes 6–12 months for toenails and 3–6 months for fingernails. Your clinician may arrange a follow-up assessment to confirm cure. A nail that appears unchanged after 6 weeks of treatment does not mean it isn't working.
No. Topical terbinafine cannot penetrate the nail plate in sufficient concentrations to treat nail fungus. Oral terbinafine is required for onychomycosis. Topical preparations are only appropriate for superficial skin infections.
For the vast majority of patients, taste disturbance resolves fully within weeks to months of stopping treatment. Persistent or permanent taste loss is rare. Inform your clinician if taste disturbance is severe or if it persists after completing the course.
Alcohol is not directly contraindicated but is best limited during treatment. Both alcohol and terbinafine are processed by the liver, and concurrent use may increase the risk of hepatotoxicity. Heavy alcohol use is an additional risk factor for liver injury.
Yes. Topical terbinafine cream applied once or twice daily for 1–2 weeks is highly effective for tinea pedis (athlete's foot). For chronic, severe, or recurring athlete's foot, oral terbinafine may be more appropriate. Good foot hygiene — keeping feet clean and dry, changing socks daily, and avoiding shared footwear — is essential to prevent recurrence.